The Press Room

FOX 2 A researcher and his team in Spain have identified a combination of drug therapies that is showing promise in pre-clinical studies for treating pancreatic cancer. Asfar Azmi, Ph.D., scientist, director of the Pancreatic Cancer Research Initiative and member of the  Molecular Therapeutics Research Program  at Karmanos, joined FOX 2 to talk about this new discovery, what it means for patients, and how he, his team, and other Karmanos colleagues are studying this disease. Dr. Azmi also shar...

WWJ The human papillomavirus (HPV) causes many cancers – one of those is cervical cancer. Radhika Gogoi, M.D., Ph.D. , gynecologic oncologist and member of the  Gynecologic Oncology Multidisciplinary Team  at Karmanos, explained the virus, the cancers that are linked to HPV, and shared the research she conducted on cervical cancer patients’ knowledge of HPV and the vaccine. Hear why Dr. Gogoi said cervical cancer could be a cancer that could eventually be eradicated. Listen here .

McLaren Health Care has presented its annual President’s Trophy to Karmanos Cancer Institute, recognizing the Detroit-based, nationally renowned cancer center with the statewide health care system’s most prestigious honor as its top-performing subsidiary. Karmanos earned this celebrated recognition through its teams’ performance in vital clinical quality and patient safety metrics, while also accounting for patient experience and satisfaction, operational excellence, research impact, and financial stewa...

94.7 WCSX Radhika Gogoi, M.D., Ph.D. , gynecologic oncologist and member of the  Gynecologic Oncology Multidisciplinary Team  at Karmanos, educated Big Jim’s listeners about cervical cancer, how this cancer type is preventable with screening, clinical trials, and getting a second opinion at Karmanos within a week. Your browser does not support the audio element. Download Podcast

Karmanos Cancer Hospital, part of the Barbara Ann Karmanos Cancer Institute , has been named one of America’s Best Hospitals for Cancer Care in 2026 by the Women’s Choice Award ® , America’s trusted referral source for the best in health care. This recognition places Karmanos among the top-performing hospitals nationwide, ranking it in the top 2% of over 4,600 U.S. hospitals that offer cancer care services. This is the 13 th consecutive year Karmanos has been recognized by the Women’s Choice Award®...

WebMD Tarik Hadid, M.D., MPH, MS, FACP , medical oncologist and member of the  Phase I Clinical Trials  and  Thoracic Oncology  Multidisciplinary Teams at Karmanos, explained what HER2-mutated non-small-cell lung cancer (NSCLC) is, why it’s important for NSCLC patients to receive genetic testing and the treatment options to treat this rare form of lung cancer. Read the article here .

BlackDoctor.org After a small-cell lung cancer diagnosis, patients have options to consider. Khalil Choucair, M.D., MSc , medical oncologist and member of the  Thoracic Oncology Multidisciplinary Team  at Karmanos, discussed some of those options, including clinical trials. Read the article here .

WDIV Catching breast cancer early, before it spreads, gives patients better treatment options and outcomes. Hadeel Assad, M.D. , medical oncologist, co-leader of the  Breast Cancer Multidisciplinary Team  (MDT), member of the  Phase I Clinical Trials MDT , joined Local 4’s Live in the D to talk about breast cancer screening, advancements in treating breast cancer, clinical trials and why women should get a second opinion when they are diagnosed with breast cancer. Watch the interview here .

Patient Power Living with chronic lymphocytic leukemia (CLL) increases a patient’s risk of being diagnosed with other cancers, especially as they age. Vijendra Singh, M.D. , medical oncologist and member of the  Hematology Oncology Multidisciplinary Team at Karmanos, shared insights into these risk factors and recent findings presented at the 2025 American Society of Hematology (ASH) Annual Meeting. Read the article here .

The Barbara Ann Karmanos Cancer Institute welcomes Khalil Choucair, M.D., MSc , medical oncologist, to the Thoracic Oncology and Phase I Clinical Trials Multidisciplinary Teams (MDT). Dr. Choucair joins the team after completing his hematology and oncology clinical fellowship at Karmanos, where he served as chief fellow and worked closely with Karmanos oncologists and scientific researchers. He began seeing patients in July 2025 at Karmanos Cancer Center in Detroit and Karmanos Cancer Institute – Dearbo...